Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Breathtaking BioNTech Projections Reveal Revenue Rebound by 2025!

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Scientific nonsense’: experts dismiss Florida official’s Covid vaccine remarks

State’s politically appointed surgeon general claims vaccines can contaminate human DNA but experts say comment has no merit

The Guardian - US

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

The Conversation

Drugmakers to Hike Prices on 500 Drugs Soon — Report

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

Kiplinger

Where Will Pfizer Stock Be in 1 Year?

PFE is a beaten-down healthcare stock that trades at a discount to consensus price target estimates. Is Pfizer stock a good buy right now?

Barchart

Read news from The Economist, FT, and more,
with one subscription

New normal? What COVID will look like in 2024

Should the government do more to support people with long-COVID?

Newcastle Herald

Men Up review: Viagra drama is a sweet tale of bonding in the face of shared misfortune

Thin characterisation and a slightly preachy message hold this 90-minute film back, but its heart is in the right place

The Independent UK

Pfizer (PFE) 2024 Preview: What to Expect From the Pharma Stock?

As Pfizer (PFE) navigates a post-pandemic world with a shifting focus away from COVID-related products, what should investors expect from this pharma giant? Let’s look at its financial metrics to know more….

StockNews.com

Inside Men Up – the Viagra drama determined to get men talking

The writer and stars of the brilliant BBC One film tell Katie Rosseinsky about delving into the origins of a drug that is so often associated with a punchline, but has irrevocably changed many people’s lives

The Independent UK

Morningstar's 10 most undervalued stocks with key market advantages

The research firm assigns wide moats to companies it thinks have competitive advantages that will last at least 20 years.

The Street

Investors Lose $426 Billion On These 8 Giant Losers This Year

Investors scored big-time on the biggest S&P 500 stocks this year. But those who picked the wrong stocks suffered mightily.

Investors Business Daily

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

mRNA COVID vaccines make 'unintended proteins' – we've discovered how to fix this problem

MRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived many of us are now familiar with it thanks to the mRNA-based vaccines.

Evening Standard

Men Up: what's the true story behind the BBC's new drama about the first Viagra trials in Wales?

In 2021, impotence affected as many as 16.5 million men in the UK; 50 per cent of the male population. But how many of them talked about it? To their friends, even to their partners? Men have always been tight-lipped about their problems – health problems even more so, and those…

Investors Business Daily

The Pain Continues For Bedraggled Pharma Heavyweight Pfizer

Another analyst cut estimates on Pfizer stock on Friday after the pharma heavyweight earlier this week issued a disappointing 2024 guide.

Barchart

I’ve Got 5 Stocks and 5 DTEs: Which Call Should I Buy?

Wednesday’s unusual options activity had multiple stocks with two or more calls expiring on the same day. Five stocks caught my interest. Only one of the calls is worth buying.

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

The Street

What's Driving the Pfizer Tumble? - The Rebel's Edge

Jon and Pete Najarian join forces to discuss and debate their favorite topics, including the hottest stock-specific news and sports! Today: $PFE, $VRTX, $PLAB, and Bowl Games

Top News

Pfizer's 2024 Revenue Forecast Fails to Meet Wall Street Expectations

Amid a dismal financial outlook for 2024 and falling sales of COVID-19 products, Pfizer shares see a 7% tumble triggering Wall Street worries.

Investors Business Daily

Pfizer Crashes 7% After Issuing A Disappointing Outlook As Seagen Takeover Looms

Pfizer stock careened lower Wednesday after the company issued disappointing 2024 guidance ahead of its acquisition of Seagen.

International Business Times

Pfizer Expects To Complete Purchase Of Seagen On Thursday

Pfizer announced Tuesday that it expects to complete this week its $43 billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.

The Street

Pfizer tumbles after muted 2024 revenue forecast, Seagen profits hit

Pfizer, which saw revenue top $100 billion in 2022, has shed more than $143 billion in market value this year.

Barchart

Stocks Move Higher as CPI Falls to 5-month Low

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. The S&P 500 climbed to a 20-month high, while...

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.